285 related articles for article (PubMed ID: 35435119)
1. Adiponectin inhibits the activation of lung fibroblasts and pulmonary fibrosis by regulating the nuclear factor kappa B (NF-κB) pathway.
Wang X; Yang J; Wu L; Tong C; Zhu Y; Cai W; Wan B; Zhang X
Bioengineered; 2022 Apr; 13(4):10098-10110. PubMed ID: 35435119
[TBL] [Abstract][Full Text] [Related]
2. Glucagon like peptide-1 attenuates bleomycin-induced pulmonary fibrosis, involving the inactivation of NF-κB in mice.
Gou S; Zhu T; Wang W; Xiao M; Wang XC; Chen ZH
Int Immunopharmacol; 2014 Oct; 22(2):498-504. PubMed ID: 25111852
[TBL] [Abstract][Full Text] [Related]
3. Adiponectin attenuates lung fibroblasts activation and pulmonary fibrosis induced by paraquat.
Yao R; Cao Y; He YR; Lau WB; Zeng Z; Liang ZA
PLoS One; 2015; 10(5):e0125169. PubMed ID: 25945502
[TBL] [Abstract][Full Text] [Related]
4. Necrostatin-1 Alleviates Bleomycin-Induced Pulmonary Fibrosis and Extracellular Matrix Expression in Interstitial Pulmonary Fibrosis.
Mou F; Mou C
Med Sci Monit; 2020 Feb; 26():e919739. PubMed ID: 32019905
[TBL] [Abstract][Full Text] [Related]
5. Stevioside attenuates bleomycin-induced pulmonary fibrosis by activating the Nrf2 pathway and inhibiting the NF-κB and TGF-β1/Smad2/3 pathways.
Hao W; Yu TT; Zuo DZ; Hu HZ; Zhou PP
Exp Lung Res; 2023 Nov; 49(1):205-219. PubMed ID: 38044666
[No Abstract] [Full Text] [Related]
6. Cepharanthine Ameliorates Pulmonary Fibrosis by Inhibiting the NF-κB/NLRP3 Pathway, Fibroblast-to-Myofibroblast Transition and Inflammation.
Chen G; Li J; Liu H; Zhou H; Liu M; Liang D; Meng Z; Gan H; Wu Z; Zhu X; Han P; Liu T; Gu R; Liu S; Dou G
Molecules; 2023 Jan; 28(2):. PubMed ID: 36677811
[TBL] [Abstract][Full Text] [Related]
7. Protective role of andrographolide in bleomycin-induced pulmonary fibrosis in mice.
Zhu T; Zhang W; Xiao M; Chen H; Jin H
Int J Mol Sci; 2013 Dec; 14(12):23581-96. PubMed ID: 24300094
[TBL] [Abstract][Full Text] [Related]
8. [Effects of andrographolide on the concentration of cytokines in BALF and the expressions of type I and III collagen mRNA in lung tissue in bleomycin-induced rat pulmonary fibrosis].
Zhu HL; Huang CL; Wang WJ; Zhan XQ; Fan XM
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2011 Jul; 27(7):725-9. PubMed ID: 21722520
[TBL] [Abstract][Full Text] [Related]
9. [Aqueous extract of Epimedium sagittatum mitigates pulmonary fibrosis in mice].
Wang R; Hou FY; Zeng MN; Zhang BB; Zhang QQ; Xie SS; Feng WS; Zheng XK
Zhongguo Zhong Yao Za Zhi; 2023 Oct; 48(20):5612-5622. PubMed ID: 38114154
[TBL] [Abstract][Full Text] [Related]
10. [The Study of the Effect and Mechanism of Glucagon Like Peptide-1 in Bleomycin-induced Pulmonary Fibrosis in Mice].
Liu M; Gou S; Chen HT; Chen ZH
Sichuan Da Xue Xue Bao Yi Xue Ban; 2017 Jul; 48(4):509-514. PubMed ID: 28752966
[TBL] [Abstract][Full Text] [Related]
11. Parthenolide attenuated bleomycin-induced pulmonary fibrosis via the NF-κB/Snail signaling pathway.
Li XH; Xiao T; Yang JH; Qin Y; Gao JJ; Liu HJ; Zhou HG
Respir Res; 2018 Jun; 19(1):111. PubMed ID: 29871641
[TBL] [Abstract][Full Text] [Related]
12. Dihydroartemisinin supresses inflammation and fibrosis in bleomycine-induced pulmonary fibrosis in rats.
Yang D; Yuan W; Lv C; Li N; Liu T; Wang L; Sun Y; Qiu X; Fu Q
Int J Clin Exp Pathol; 2015; 8(2):1270-81. PubMed ID: 25973011
[TBL] [Abstract][Full Text] [Related]
13. Fucoxanthin inhibits profibrotic protein expression in vitro and attenuates bleomycin-induced lung fibrosis in vivo.
Ma SY; Park WS; Lee DS; Choi G; Yim MJ; Lee JM; Jung WK; Park SG; Seo SK; Park SJ; Han IY; Choi YH; Choi IW
Eur J Pharmacol; 2017 Sep; 811():199-207. PubMed ID: 28642129
[TBL] [Abstract][Full Text] [Related]
14. Fluorofenidone attenuates pulmonary inflammation and fibrosis via inhibiting the activation of NALP3 inflammasome and IL-1β/IL-1R1/MyD88/NF-κB pathway.
Song C; He L; Zhang J; Ma H; Yuan X; Hu G; Tao L; Zhang J; Meng J
J Cell Mol Med; 2016 Nov; 20(11):2064-2077. PubMed ID: 27306439
[TBL] [Abstract][Full Text] [Related]
15. [Chrysin inhibited epithelial-mesenchymal transition of type Ⅱ alveolar epithelial cell by regulating NF-κB/Twist 1 signaling pathway].
Lu LM; Fu Y; Li QY; He XW; Tang J; Li XW
Zhongguo Zhong Yao Za Zhi; 2021 Jan; 46(1):146-154. PubMed ID: 33645064
[TBL] [Abstract][Full Text] [Related]
16. Ganoderic Acid A Inhibits Bleomycin-Induced Lung Fibrosis in Mice.
Wen G; Li T; He H; Zhou X; Zhu J
Pharmacology; 2020; 105(9-10):568-575. PubMed ID: 31940650
[TBL] [Abstract][Full Text] [Related]
17. Mangiferin attenuates bleomycin-induced pulmonary fibrosis in mice through inhibiting TLR4/p65 and TGF-β1/Smad2/3 pathway.
Jia L; Sun P; Gao H; Shen J; Gao Y; Meng C; Fu S; Yao H; Zhang G
J Pharm Pharmacol; 2019 Jun; 71(6):1017-1028. PubMed ID: 30847938
[TBL] [Abstract][Full Text] [Related]
18. Astragalus polysaccharide attenuates bleomycin-induced pulmonary fibrosis by inhibiting TLR4/ NF-κB signaling pathway and regulating gut microbiota.
Wei Y; Qi M; Liu C; Li L
Eur J Pharmacol; 2023 Apr; 944():175594. PubMed ID: 36804541
[TBL] [Abstract][Full Text] [Related]
19. Salidroside protects against bleomycin-induced pulmonary fibrosis: activation of Nrf2-antioxidant signaling, and inhibition of NF-κB and TGF-β1/Smad-2/-3 pathways.
Tang H; Gao L; Mao J; He H; Liu J; Cai X; Lin H; Wu T
Cell Stress Chaperones; 2016 Mar; 21(2):239-49. PubMed ID: 26577463
[TBL] [Abstract][Full Text] [Related]
20. Hydrogen inhalation attenuated bleomycin-induced pulmonary fibrosis by inhibiting transforming growth factor-β1 and relevant oxidative stress and epithelial-to-mesenchymal transition.
Gao L; Jiang D; Geng J; Dong R; Dai H
Exp Physiol; 2019 Dec; 104(12):1942-1951. PubMed ID: 31535412
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
